RxDoctor Payments Data

Autumn Burkman, CNM

Advanced Practice Midwife · Columbus, INNPI 1144907155

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $418, 3.1 times the $134 reported in 2023.

$797in general payments, 2019–2025

Across 38 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$145
  • Sumitomo Pharma America, Inc.$138
  • AbbVie$114
  • Axonics, Inc.$91
  • Astellas Pharma US Inc$48
  • Dexcom, Inc.$44
  • plus $219 from 9 others

What the payments were for

  • Food & beverage$797100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$797 in reported general payments places this provider in the 85th percentile of 151 advanced practice midwife providers in Indiana.

See all advanced practice midwife providers in Indiana

Medicare billing

Part B allowed, 2024
$2,905
Medicare patients
25
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Medroxyprogesterone Acetate16$186

Paid to pharmacies, not to this prescriber.

Other advanced practice midwife in Columbus

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →